Prioritise people with HIV for COVID-19 vaccination.
作者信息
Hiv The Lancet
出版信息
Lancet HIV. 2021 Nov;8(11):e659. doi: 10.1016/S2352-3018(21)00278-2.
Abstract
摘要
相似文献
1
Prioritise people with HIV for COVID-19 vaccination.将感染艾滋病毒的人列为新冠疫苗接种的优先对象。
Lancet HIV. 2021 Nov;8(11):e659. doi: 10.1016/S2352-3018(21)00278-2.
2
Acute HIV infection syndrome mimicking COVID-19 vaccination side effects: a case report.急性 HIV 感染综合征模拟 COVID-19 疫苗副作用：病例报告。
AIDS Res Ther. 2021 Oct 26;18(1):78. doi: 10.1186/s12981-021-00407-2.
3
SARS-CoV-2 vaccination in people with HIV.艾滋病毒感染者接种新型冠状病毒2型疫苗
Lancet HIV. 2021 Aug;8(8):e455-e456. doi: 10.1016/S2352-3018(21)00128-4. Epub 2021 Jun 18.
4
[Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients with HIV infection].[关于人类免疫缺陷病毒（HIV）感染患者新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种的专家建议]
Zhonghua Nei Ke Za Zhi. 2021 Jul 1;60(7):615-618. doi: 10.3760/cma.j.cn112138.20210403-00259.
5
[SARS-CoV-2 vaccination in people living with HIV].[HIV感染者中的新型冠状病毒2型疫苗接种]
MMW Fortschr Med. 2022 Jun;164(Suppl 2):34-39. doi: 10.1007/s15006-022-1021-x.
6
Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2.新冠病毒感染后与 SARS-CoV-2 疫苗接种的感染后免疫
Viral Immunol. 2021 Oct;34(8):504-509. doi: 10.1089/vim.2021.0054. Epub 2021 Jul 5.
7
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome.监狱服刑人员中的新冠病毒疫苗接种：有待克服的障碍
Front Public Health. 2021 Aug 12;9:704520. doi: 10.3389/fpubh.2021.704520. eCollection 2021.
8
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
9
[Not Available].[无可用内容]
MMW Fortschr Med. 2022 Apr;164(7):17. doi: 10.1007/s15006-022-1052-3.
10
Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination.对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种、既往SARS-CoV-2感染的抗体反应以及改为单剂量接种。
J Med Virol. 2021 Dec;93(12):6474. doi: 10.1002/jmv.27263. Epub 2021 Aug 12.
引用本文的文献
1
Tolerance of Inactivated SARS-CoV-2 Vaccine for People Living with HIV: A Real-World Evidence Analysis from a Retrospective Cohort Study.HIV感染者对新型冠状病毒灭活疫苗的耐受性：一项回顾性队列研究的真实世界证据分析
J Epidemiol Glob Health. 2025 Aug 14;15(1):106. doi: 10.1007/s44197-025-00452-4.
2
Time-to-completion of COVID-19 vaccination primary series varies by HIV viral load status among people who inject drugs in Baltimore, Maryland.在马里兰州巴尔的摩市注射毒品的人群中，完成新冠病毒疫苗基础免疫系列的时间因艾滋病毒病毒载量状态而异。
Prev Med Rep. 2023 Sep 28;36:102448. doi: 10.1016/j.pmedr.2023.102448. eCollection 2023 Dec.
3
Effectiveness and Safety of SARS-CoV-2 Vaccination in HIV-Infected Patients-Real-World Study.HIV感染患者中SARS-CoV-2疫苗接种的有效性和安全性——真实世界研究
Vaccines (Basel). 2023 Apr 24;11(5):893. doi: 10.3390/vaccines11050893.
4
HIV and COVID-19: A Tale of Two Pandemics.艾滋病毒与新冠病毒：两场大流行的故事
Curr HIV Res. 2022;20(5):344-349. doi: 10.2174/1570162X20666220823110435.
5
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China.中国HIV感染者中新型冠状病毒灭活疫苗的安全性和免疫原性
Infect Drug Resist. 2022 Apr 21;15:2091-2100. doi: 10.2147/IDR.S353127. eCollection 2022.
Zotero 插件